Skip to Main Content

Paper Details

Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach.
J Med Chem
76
2015
CO-1686, Cys797, EGFR, EGFR-T790M, L858R, NSCLC, NSCLC cell lines, Receptor tyrosine kinases, S345C, T338M, T790M, cancer, engineered cSrc, epidermal growth factor receptor, non-small cell lung cancer, tyrosine
Author NameAffiliation
Christian GrütterTU Dortmund University
Martin L SosUniversity of Cologne
Martin L SosUniversity Hospital of Cologne
  • 1 - 3

Datasets

Release 1.2